Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948) [Phase 2]

View source ↗

Summary

Phase 2 study to evaluate safety and efficacy of Caelyx in combination with cyclophosphamide for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED